Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,019 total articles
Sumitomo Mitsui Financial Group (SMFG) is trading near its 52-week high but still looks attractive: market cap ~$159.8B, P/E ~15.4, P/B ~1.62 and a 2.16% yield. With higher domestic rates feeding net interest income and technicals showing momentum, I recommend a long trade sized for conviction with a $25.00 entry, $28.00 target and $23.00 stop over…
Immersion (IMMR) trades at a sub-$250M market cap with attractive valuation multiples (P/B ~0.75, EV/Sales ~0.12) and a 3.6% yield. The business is licensing-heavy with recurring royalties and a deep patent portfolio in haptics. For investors willing to tolerate uneven cash flow, a disciplined long position around $6.48 targets the $8.15 52-week hi…
Amazon shares are trading below $240 after a sharp pullback. With AWS capturing outsized AI infrastructure demand, modest multiple expansion on current earnings could lift the stock into the $290s. This trade idea lays out an actionable long with entry, stop and target, plus catalysts and risks to monitor.
Braze just reported another beat-and-raise quarter with revenue growth accelerating to ~30% and management launching a meaningful buyback. At a $2.1B market cap, the stock looks like a high-conviction swing trade: entry near $18.50, protective stop at $16.50 and a 45-trading-day target of $26.00. The case rests on continued top-line momentum, bette…
REalloys (ALOY) has moved from story stock to execution stage: a $20.6m investment in Saskatchewan processing, a 15-year offtake for Tanbreez heavy rare earths, and fresh capital position the company to capture premium pricing ahead of the Pentagon's 01/01/2027 ban on Chinese-origin rare earths. The technical set is frothy, but fundamentals and str…
Merck's oncology franchise remains the engine pushing the company higher. With Keytruda still dominant across multiple indications, an expanding slate of oncology programs, a $14.1B free cash flow runway and a $281B market cap, MRK looks attractive for a defined, 180-trading-day long trade. Entry at $114.00, stop at $106.00, target $130.00.
Forgent Power Solutions (FPS) is positioned to benefit from a multi-year data-center power refresh. Momentum indicators are constructive, volume is rising, and short interest remains manageable. We lay out an actionable mid-term swing trade with entry at $62.15, a $75 target and a $56 stop, and explain the fundamental and technical evidence behind …
Alamos Gold looks attractively discounted relative to its quality: steady production profile, low jurisdictional risk, and sensible capital allocation. We upgrade to a long trade with a clear entry, stop and target across a mid-term horizon, framing catalysts and risks that could drive a re-rating.
Lam Research sits at the intersection of an AI-driven memory supercycle, accelerated packaging complexity, and renewed chip-equipment capex. The company’s profitability, cash generation and low leverage justify buying on strength with a disciplined stop. I recommend a long trade with an entry at $397.24, a stop loss at $345.00 and a target at $520.…
The software dip through spring felt indiscriminate. XSW - an equal-weighted software & services ETF trading at $162.54 - now offers three concrete trade plans for different horizons that balance upside back toward the 52-week range with disciplined stops near the recent low. The setup is supported by valuation gaps, moderate short interest, and te…
Remitly turned profitable in 2025 after a period of heavy reinvestment and now trades at a reasonable multiple vs. its growth runway. With $1.64B revenue, 9.3M customers, and $243M in free cash flow, the company looks set to compound while expanding margins through scale, AI fraud reduction, and platform integrations. This trade idea lays out an ac…
Summit Therapeutics (SMMT) is a binary, catalyst-driven biotech trade centered on the FDA's PDUFA date for ivonescimab on 11/14/2026. The company trades at a $10.8B market cap, heavy short interest, and material intraday volume swings. This idea is a high-risk long with a defined entry, stop and target—intended for traders looking to play the appro…
Uber's platform value still comes from how demand is distributed across its Mobility, Delivery and Freight businesses. With a market cap near $145B, FCF of roughly $9.1B and a P/E in the high teens, the risk/reward favors a measured long on a pullback while the market sorts autonomous mobility narratives. This trade targets $82 with a defined stop …
SiTime's silicon MEMS timing franchise is positioned to benefit materially from AI datacenter and communications demand. The Renesas timing acquisition announced on 02/04/2026 accelerates a path to $1B in revenue and meaningfully improves gross margins; yet the market's current price implies a stretched growth premium. This trade idea targets a dis…
Alibaba (BABA) is sitting on technically oversold levels with RSI at 23 and price within a few dollars of its 52-week low. The company’s diversified commerce ecosystem and expanding cloud business create a credible path to earnings recovery. This trade idea lays out a mid-term long entry at $105.00, a stop loss at $98.00, and a target of $140.00 ov…
Microsoft is trading near its 52-week low with attractive cash generation, a reasonable P/E of ~22.6, and an RSI that signals oversold conditions. This trade idea outlines a mid-term (45 trading days) long with concrete entry, stop and target, backed by balance-sheet strength, free cash flow of ~$72.9B and catalysts tied to AI adoption and corporat…
Howmet Aerospace (HWM) sits at the intersection of several secular trends - expanding commercial aerospace production, rising defense modernization and autonomy spending, and reshoring of critical manufacturing. The company combines attractive margins and free cash flow with a premium valuation. This trade idea lays out a long entry at $277.00, a s…
OPKO (OPK) is trading near $1.44 with a market cap ~ $1.08B and an enterprise value roughly the same. The company carries valuable diagnostics assets, an active pharma R&D slate (recently expanding a collaboration on an oral PTH program), and technical indicators that favor mean reversion. Given modest leverage, reasonable valuation multiples (EV/S…
PPL (PPL) is a regulated U.S. utility with a $26.7B market cap that looks poised to benefit from renewed spending on grid resilience and reliability. The company trades at ~21.8x earnings and yields ~3.1%. We lay out a mid-term swing trade to capture a re-rating as energy security becomes a growth driver—entry $35.575, target $40.00, stop $33.50 ov…
Occidental Petroleum (OXY) is a high-conviction, actionable long that offers roughly 25% upside to our $64.10 target if crude oil climbs back toward $70/barrel. The company’s $51B market cap, $3.6B of annual free cash flow, modest leverage (debt/equity ~0.4) and recent portfolio moves position it to outperform on a recovering oil price. This trade …
Weibo (WB) trades near its 52-week low with a market cap around $1.82B, an 8% dividend yield and depressed multiples. For patient, risk-aware traders the setup offers asymmetric upside to analyst targets near $10.5 while downside is capped by an inexpensive balance-sheet multiple.
Lexeo Therapeutics's LX2006 has produced consistent interim signals of clinical activity in Friedreich ataxia cardiomyopathy and the company has active regulatory engagement with the FDA around accelerated and registrational pathways. With a sub-$400M market cap, visible milestones and recent balance-sheet reinforcement, LXEO is a high-risk, high-r…
Nano Labs (NA) trades at roughly $46.7M market cap and just $2.01 per share, yet the company designs high-performance AI and vision chips and has several near-term catalysts (North America MOU, product launches, and CEO share buys). Technicals are mixed but sentiment and short interest suggest a squeeze potential. This trade idea lays out an action…
HEICO (HEI) combines high-margin aftermarket parts with a diversified electronics business. Recent beats in both Flight Support Group and Electronic Technologies Group, plus strong free cash flow ($944M), support continued EBITDA compounding. Valuation is rich (EV/EBITDA ~36x, P/E ~60x) so enter with a disciplined stop and a long-term horizon to le…
Standard Motor Products (SMP) looks inexpensive relative to its cash generation and recent acquisition-driven growth. Q1 2026 revenue of $451.2M (up 9.1% YoY), adjusted EBITDA of $44.5M and free cash flow of roughly $39.4M underpin a durable payout, an elevated dividend yield near 3.3% and an EV/EBITDA of ~8.2. For investors willing to accept modes…
